JFG
TBPH icon

Jefferies Financial Group’s Theravance Biopharma TBPH Stock Holding History

Jefferies Financial Group’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-276,887
Closed -$3.05M – 1673
2025
Q2 		$3.05M Buy
276,887
+255,455
+1,192% +$2.48M 0.03% 423
2025
Q1 		$191K Buy
+21,432
New +$199K ﹤0.01% 1398
2023
Q4 		– Sell
-302,130
Closed -$2.61M – 1989
2023
Q3 		$2.61M Buy
302,130
+2,130
+0.7% +$20.6K 0.02% 534
2023
Q2 		$3.1M Buy
+300,000
New +$3.31M 0.03% 516

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jefferies Financial Group's TBPH Position: Q3 2025 in Review

Jefferies Financial Group sold out of Theravance Biopharma (TBPH) in Q3 2025, closing a stake of 276,887 shares — an estimated $3.05M sold.

Jefferies Financial Group first reported a position in TBPH in Q2 2023 and held it in 4 quarters. The position peaked at $3.1M in Q2 2023. 162 funds tracked by Wall St. Rank hold TBPH as of Q3 2025.

  • Jefferies Financial Group reported no remaining Theravance Biopharma position as of Q3 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 276,887 Theravance Biopharma shares in Q3 2025, an estimated $3.05M.
  • Jefferies Financial Group first reported a position in Theravance Biopharma in Q2 2023 and held it in 4 quarters.
  • Jefferies Financial Group's Theravance Biopharma position peaked at $3.1M in Q2 2023.
  • 162 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2025.

Based on Jefferies Financial Group's 13F filing for Q3 2025, filed 13 Nov 2025.